• PDF / 123,439 Bytes
• 1 Pages / 623.591 x 841.847 pts Page_size
• 26 Downloads / 188 Views

DOWNLOAD

REPORT

1173-5503/10/0533-0001/$14.95 Adis © 2010 Springer International Publishing AG. All rights reserved

PharmacoEconomics & Outcomes News 28 Jul 2007 No. 533

1

Recommend Documents

Androgen Deprivation Therapy

180 84 7MB

Androgen deprivation therapy increases risk of dementia

149 19 166KB

Toxicity of Androgen Deprivation Therapy in Hormone-Sensitive Prostate Cancer

204 15 418KB

HSD3B1 variant and androgen-deprivation therapy outcome in prostate cancer

178 5 2MB

Dementia risk varies by type of androgen deprivation therapy

175 3 148KB

QOL

145 35 57MB

Living with Advanced Hormone-Sensitive Prostate Cancer and Treatment with Abiraterone and Androgen Deprivation Therapy:

170 74 504KB

Positive QOL

167 49 57MB

CP-QOL

172 40 57MB

VEINES-QOL

156 86 57MB

Does androgen-deprivation therapy increase the risk of ischemic cardiovascular and cerebrovascular diseases in patients

155 95 977KB

Phase I/IIa trial of androgen deprivation therapy, external beam radiotherapy, and stereotactic body radiotherapy boost

157 67 848KB